It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
There is growing optimism that multiple myeloma is on its way to become a chronic disease. The improving survival rate is partly attributed to the efforts of physicians like Dr. Fredrik Schjesvold from the Oslo Myeloma Center at Oslo University Hospital. Listen to our podcast as Dr. Schjesvold describes his efforts to build an infrastructure that will make Norway an attractive partner for early phase studies, and the progress that is being made to predict how well patients respond to treatment and the ability to identify the best, least toxic treatment option.